• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Treatment targeting RAGE signal by microRNA in diabetic nephropathy

Research Project

Project/Area Number 18K08220
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 53040:Nephrology-related
Research InstitutionJuntendo University

Principal Investigator

Hagiwara Shinji  順天堂大学, 医学部, 准教授 (70445568)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords糖尿病性腎症 / miRNA / RAGE / PAI-1 / microRNA / 糖尿病 / 腎線維化 / マイクロRNA / Diaph1
Outline of Final Research Achievements

Advanced glycation end product (AGE) promotes fibrosis via AGE receptor (RAGE) and is greatly involved in the development of diabetic nephropathy. We focused on miR-199a, which was highly expressed in the mesangial cells extracted from RAGE knockout mouse that was shown to be protected against diabetic nephropathy. Overexpression of miR-199a in mouse mesangial cells decreased PAI-1 expression, and knocking down of miR-199a increased PAI-1 expression. In addition, TGF-β stimulation reduced the expression of miRNA-199a. As a result of comparing the expression levels of fibrotic markers, it was suggested that miR-199a has an antifibrotic effect in mesangial cells. It has been predicted that PAI-1 is the target gene for miRNA-199a from the database (TargetScan) and will be confirmed using the 3'UTR reporter assay in the future.

Academic Significance and Societal Importance of the Research Achievements

miRNAは細胞シグナルを調整するメディエーターであり、腎障害が出現する以前にそのプロファイルに変化が認められるため、そのプロファイルの解析により早期に腎障害を予測できる可能性がある。また糖尿病性腎症の線維化に関連するmiRNAを解析することで、早期診断およびmiRNAを用いた新しい治療法を開発することは、末期腎不全に対する腎代替療法の医療費削減にも有用であると考えられる。
申請者らこれまで糖尿病性腎症に対して腎保護作用が示されているRAGE KOマウスにおいて過剰発現したmiRNAを同定しており、着目したmiRNAの糖尿病性腎症における影響を検証することは非常に興味深いと考えている。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (4 results)

All 2021 2020 2019

All Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results) (of which Int'l Joint Research: 2 results) Book (1 results)

  • [Journal Article] Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs2020

    • Author(s)
      Sakuma Hiroko、Hagiwara Shinji、Kantharidis Phillip、Gohda Tomohito、Suzuki Yusuke
    • Journal Title

      Frontiers in Pharmacology

      Volume: 11 Pages: 1-9

    • DOI

      10.3389/fphar.2020.587689

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] THE EXPRESSION AND THE ROLE OF MICRORNA IN RAGE KNOCK OUT MOUSE MESANGIAL CELLS2019

    • Author(s)
      Shinji Hagiwara, Yusuke Suzuki, Tomohito Gohda, Kazuhiko Funabiki, Mark Cooper, Phillip Kantharidis
    • Organizer
      World Congress of Nephrology 2019
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] THE EXPRESSION AND THE ROLE OF MICRORNA IN RAGE KNOCK OUT MOUSE MESANGIAL CELLS2019

    • Author(s)
      Shinji Hagiwara
    • Organizer
      World Congress of Nephrology 2019
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Book] 糖尿病性腎臓病の病態と治療(第3章病態生理:C.線維化・細胞外基質・microRNA )2021

    • Author(s)
      萩原晋二, 富野 康日己 (監) / 和田 隆志 , 合田 朋仁 (編)
    • Total Pages
      270
    • Publisher
      中外医学社
    • ISBN
      9784498224681
    • Related Report
      2020 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi